ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 576,34
0,26%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) Actualités

VNDA Vanda Pharmaceuticals Inc

4,5199
0,0399 (0,89%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0399 0,89% 4,5199 01:05:06
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,57 4,45 4,625 4,62 4,48
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202414:05GLOBEShareholder Capital Delivers Letter to Independent Members..
23/4/202401:13PRNUSVanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial..
17/4/202416:21PRNUSVanda Pharmaceuticals Adopts Limited Duration Stockholder..
17/4/202415:02PRNUSVanda Pharmaceuticals Confirms Rejection of Unsolicited..
03/4/202416:25APSBiotech Catches Major Premarket Bid Following FDA Approval
03/4/202400:10PRNUSVanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S...
07/3/202422:31EDGAR2Form 8-K - Current report
06/3/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
05/3/202403:14EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:12EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:10EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:08EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:06EDGAR2Form 144 - Report of proposed sale of securities
21/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:32EDGAR2Form 8-K - Current report
16/2/202422:31EDGAR2Form 8-K/A - Current report: [Amend]
08/2/202413:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/2/202422:07EDGAR2Form 8-K - Current report
07/2/202422:02PRNUSVanda Pharmaceuticals Reports Fourth Quarter and Full Year..
05/2/202422:34EDGAR2Form 8-K - Current report
05/2/202414:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
31/1/202422:30PRNUSVanda Pharmaceuticals to Announce Fourth Quarter and Full..
31/1/202415:00PRNUSVanda Pharmaceuticals Receives FDA Approval to Proceed with..
30/1/202418:35PRNUSCourt Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag..
30/1/202401:00PRNUSCourt Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag..
26/1/202404:05PRNUSVanda Pharmaceuticals Announces a U.S. Patent Allowance for..
25/1/202419:07PRNUSVanda Pharmaceuticals announces the publication of an..
23/1/202417:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202415:15PRNUSVanda Pharmaceuticals Receives FDA Approval to Proceed with..
19/1/202422:57DJNVanda Pharma's Trade Secrets Suit Against FDA Moves Forward
19/1/202421:56PRNUSFederal Court Allows Vanda Pharmaceuticals' Lawsuit to..
17/1/202421:46PRNUSVanda Pharmaceuticals announces the publication of Efficacy..
12/1/202418:21PRNUSVanda Pharmaceuticals Comments on FDA's Recently Announced..
04/1/202422:30PRNUSVanda Pharmaceuticals Announces Participation in the J.P...
15/12/202322:15EDGAR2Form 8-K - Current report
07/12/202323:19EDGAR2Form 8-K - Current report
07/12/202313:00PRNUSVanda Pharmaceuticals Acquires U.S. and Canadian Rights to..
05/12/202312:23DJNVanda Pharmaceuticals Shares Rise Premarket on FDA Review of..
05/12/202300:45DJNVanda Pharma Says FDA Accepts New Drug Application for..
05/12/202300:00PRNUSVanda Pharmaceuticals Announces that U.S. Food and Drug..
09/11/202322:30PRNUSVanda Pharmaceuticals Announces Participation at November..

Dernières Valeurs Consultées

NASDAQ
VNDA
Vanda Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés